Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-familiar routine of meetings, deadlines, and what-not has predictably returned. But what can you do? The world keeps spinning, after all. So to cope, yes, we are in the Pharmalot cafeteria brewing cups of stimulation. Our choice today is cinnamon dolce, for those tracking this sort of thing. Meanwhile, here are some fresh tidbits for you to devour. We hope you have a smashing day and do keep in touch.

White House trade advisor Peter Navarro advocated for bringing home more of the U.S. pharmaceutical supply chain amid the coronavirus in China, Fox Business reports. “We’ve off-shored far too much of our supply chain, not just for corona, but also for the essential medicines we need. Same reasons we off-shored a lot of our other stuff: it’s a cheap labor environment, lax environment, and most of all, unfair trade practices. … On the supply chain issue, for the American people they need to understand that in crises like this we have no allies.”


Some of the largest drug makers, including Pfizer (PFE) and Eli Lilly (LLY), have developed a blockchain-based system to track prescription drugs across the supply chain to better halt the flow of counterfeit medicines, Reuters reports. Some two dozen companies, including distributors, retailers, and delivery companies, created the blockchain-based MediLedger Network, which it has been testing in the verification of drug returns. They intend to expand the system this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!